Kunti Wijiarti
Research Subjects
Kunti Wijiarti has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Aninda Dinar Widiantari
Clinical Research Unit, Sulianti Saroso Infectious Disease Hospital, Jakarta, Indonesia
2 shared publications - Maria Lawrensia Tampubolon
Department of Neurology, Sulianti Saroso Infectious Disease Hospital, Jakarta, Indonesia
2 shared publications - Nina Mariana
Affiliations Doctoral program in Medical Sciences, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia, Directorate Of Human Resources-Education and Research, National Infectious Disease Center - Sulianti Saroso Hospital, Jakarta, Indonesia
2 shared publications - Rivaldiansyah Rivaldiansyah
Clinical Research Unit, Sulianti Saroso Infectious Disease Hospital, Jakarta, Indonesia
2 shared publications - Siti Maemun
Research Team, Sulianti Saroso Infectious Disease Hospital; Department of Public Health, Faculty of Health Sciences, Universitas Respati Indonesia, Jakarta
2 shared publications - Tiara Zakiyah Pratiwi
Clinical Research Unit, Sulianti Saroso Infectious Disease Hospital, Jakarta, Indonesia
2 shared publications
Latest Publications
- Open Access
- 25 June 2026
- Published by Oriental Scientific Publishing Company in Biomedical and Pharmacology Journal
- Vol. 2 (19) , 1668
A Five-Year Epidemiological Study on The Profile of In-hospital Deaths in Sulianti Saroso Infectious Disease Hospital
To develop an appropriate health program, it is essential to understand the specific causes of death, especially those reported on death certificates from health facilities. This cross-sectional study aimed to analyse the sociodemographic data associated with in-hospital deaths in Sulianti Saroso Infectious Disease Hospital (SSIDH), a national infectious disease center in Indonesia. Which analyzed 1,567 Medical Certifications of Cause of Death (MCCD) forms collected from January 2018 to December 2022 at Sulianti Saroso Infectious Disease Hospital. The International Classification of Diseases, 10th revision (ICD-10) was used to report causes of death. The data analysis of patient mortality revealed trends in minimum and maximum values, as well as median and frequency distribution patterns. Deaths in males predominated (63.1%). The median age was 53 years and the median Length of Stay (LOS) was five days. Most deaths occurred in adults and within ten days of hospitalization. Respiratory diseases were the leading cause, while infectious and parasitic diseases were the main underlying cause in males. There was a significant difference between age groups and the distribution of causes of death based on ICD-10 chapters (p < 0.001). Conversely, gender showed no significant difference in the distribution of either underlying or immediate causes of death (p = 0.161 and p = 0.342). Meanwhile, LOS had a significant correlation with the distribution of both underlying and immediate causes of death (p < 0.001). Male mortality rates were over twice those of females, with the highest deaths occurring in the elderly. Respiratory disorders were the major cause of mortality, particularly in patients with a stay of more than 48 hours.The use of MCCD and hospital medical records may result in misclassification of causes of death. As the study was conducted in a single infectious disease referral hospital during the COVID-19 pandemic, the findings may not represent the general population. Additionally, the descriptive design cannot establish causal relationships.
- 25 June 2026
- Published by Oriental Scientific Publishing Company in Biomedical and Pharmacology Journal
- Vol. 2 (19) , 1668
Open AccessA Five-Year Epidemiological Study on The Profile of In-hospital Deaths in Sulianti Saroso Infectious Disease Hospital
To develop an appropriate health program, it is essential to understand the specific causes of death, especially those reported on death certificates from health facilities. This cross-sectional study aimed to analyse the sociodemographic data associated with in-hospital deaths in Sulianti Saroso Infectious Disease Hospital (SSIDH), a national infectious disease center in Indonesia. Which analyzed 1,567 Medical Certifications of Cause of Death (MCCD) forms collected from January 2018 to December 2022 at Sulianti Saroso Infectious Disease Hospital. The International Classification of Diseases, 10th revision (ICD-10) was used to report causes of death. The data analysis of patient mortality revealed trends in minimum and maximum values, as well as median and frequency distribution patterns. Deaths in males predominated (63.1%). The median age was 53 years and the median Length of Stay (LOS) was five days. Most deaths occurred in adults and within ten days of hospitalization. Respiratory diseases were the leading cause, while infectious and parasitic diseases were the main underlying cause in males. There was a significant difference between age groups and the distribution of causes of death based on ICD-10 chapters (p < 0.001). Conversely, gender showed no significant difference in the distribution of either underlying or immediate causes of death (p = 0.161 and p = 0.342). Meanwhile, LOS had a significant correlation with the distribution of both underlying and immediate causes of death (p < 0.001). Male mortality rates were over twice those of females, with the highest deaths occurring in the elderly. Respiratory disorders were the major cause of mortality, particularly in patients with a stay of more than 48 hours.The use of MCCD and hospital medical records may result in misclassification of causes of death. As the study was conducted in a single infectious disease referral hospital during the COVID-19 pandemic, the findings may not represent the general population. Additionally, the descriptive design cannot establish causal relationships.
- Open Access
- 21 April 2025
- Published by Narra Sains Indonesia in Narra J
- Vol. 5 (2) , e1936
Biomarkers for predicting COVID-19 mortality: A study at Sulianti Saroso Infectious Disease Hospital, Indonesia
The high transmissibility and mortality rates of the COVID-19 pandemic pose significant challenges. Patients can deteriorate rapidly, making it crucial to identify laboratory biomarkers for high-risk individuals. The aim of this study was to evaluate the predictive value of various laboratory parameters, including C-reactive protein (CRP), D-dimer, ferritin, neutrophil-to-lymphocyte ratio (NLR), prothrombin time (PT), and procalcitonin (PCT), in predicting COVID-19 mortality. A retrospective cohort study was conducted at Sulianti Saroso Infectious Disease Hospital, where COVID-19 patients were categorized into survivors and non-survivors. The Mann-Whitney test was used to assess group differences, while receiver operating characteristic (ROC) curve analysis was performed to evaluate the predictive performance of each biomarker, with Youden's index (J) determining optimal cut-off values. Kaplan-Meier analysis was used to compare median survival times, and Cox regression assessed hazard rates and the relationship between biomarkers and mortality. A total of 1,598 patients were analyzed, the majority of whom were admitted with oxygen saturation levels >95% and classified as having mild to moderate disease severity. Among them, 216 patients died, resulting in a mortality rate of 13.52%. Significant variations in mortality rates were observed along the survival functions for NLR, ferritin, D-dimer, CRP, and PCT (p<0.001). The survival curves for these biomarkers demonstrated distinct trends across tertiles over time. Among hematological markers, NLR was significantly associated with mortality (p<0.001), with a 1.5–2.2% increased risk per unit increase. Biochemical markers (complete blood count) proved to be more effective than hematological parameters (NLR, ferritin, PT, D-dimer, CRP, PCT) when evaluating individual prognostic performance. Bivariate analysis of CRP, D-dimer, ferritin, NLR, PT, and PCT between survivors and non-survivors showed significant differences. Notably, NLR and PCT were highly relevant for predicting disease prognosis and mortality, with sensitivity and specificity values exceeding 80%.
- 21 April 2025
- Published by Narra Sains Indonesia in Narra J
- Vol. 5 (2) , e1936
Open AccessBiomarkers for predicting COVID-19 mortality: A study at Sulianti Saroso Infectious Disease Hospital, Indonesia
The high transmissibility and mortality rates of the COVID-19 pandemic pose significant challenges. Patients can deteriorate rapidly, making it crucial to identify laboratory biomarkers for high-risk individuals. The aim of this study was to evaluate the predictive value of various laboratory parameters, including C-reactive protein (CRP), D-dimer, ferritin, neutrophil-to-lymphocyte ratio (NLR), prothrombin time (PT), and procalcitonin (PCT), in predicting COVID-19 mortality. A retrospective cohort study was conducted at Sulianti Saroso Infectious Disease Hospital, where COVID-19 patients were categorized into survivors and non-survivors. The Mann-Whitney test was used to assess group differences, while receiver operating characteristic (ROC) curve analysis was performed to evaluate the predictive performance of each biomarker, with Youden's index (J) determining optimal cut-off values. Kaplan-Meier analysis was used to compare median survival times, and Cox regression assessed hazard rates and the relationship between biomarkers and mortality. A total of 1,598 patients were analyzed, the majority of whom were admitted with oxygen saturation levels >95% and classified as having mild to moderate disease severity. Among them, 216 patients died, resulting in a mortality rate of 13.52%. Significant variations in mortality rates were observed along the survival functions for NLR, ferritin, D-dimer, CRP, and PCT (p<0.001). The survival curves for these biomarkers demonstrated distinct trends across tertiles over time. Among hematological markers, NLR was significantly associated with mortality (p<0.001), with a 1.5–2.2% increased risk per unit increase. Biochemical markers (complete blood count) proved to be more effective than hematological parameters (NLR, ferritin, PT, D-dimer, CRP, PCT) when evaluating individual prognostic performance. Bivariate analysis of CRP, D-dimer, ferritin, NLR, PT, and PCT between survivors and non-survivors showed significant differences. Notably, NLR and PCT were highly relevant for predicting disease prognosis and mortality, with sensitivity and specificity values exceeding 80%.